Dr. Ajaykumar Yadav, Group Head of Clinical Research at Reliance Life Sciences stated, "The Investigator Meeting was a successful milestone in the preparation for Monogram's clinical trial.

Roth MKM raised the firm’s price target on Monogram Orthopaedics (MGRM) to $5.40 from $4 and keeps a Buy rating on the shares.Light Up your ...

Monogram received FDA 510(k) clearance for its robotic-assisted total knee arthroplasty system, Monogram mBôs TKA. The company plans initial placements with key surgeons and aims to expand its ...

I'm incredibly impressed and confident that surgeons will recognize the impact of this system," said Dr. Douglas Unis, Founder and Chief Medical Officer of Monogram. "Navigating a regulatory ...